Esmeralda Herrero BSc. PhD

 

Esmeralda Herrero graduated from University College Dublin (UCD) with a BSc in Pharmacology and completed a PhD in Microbiology in University College Dublin. Her research investigated bacterial proteases and their role in prion decontamination and was filed into a UK patent in 2015. Following her PhD, Esmeralda worked for a year as research and development scientist for a novel biotech company before her role as scientific officer in virology in airmid healthgroup.

Esmeralda has over 5 years research experience in mammalian cell culture, molecular biology, bacterial culturing, infectious assays, protein purification, protein biochemistry and laboratory management

 

Tristan Russell BSc. PhD

 

Tristan graduated from the University of Leeds with a BSc in Microbiology. During his degree, Tristan completed a one-year internship at a pharmaceutical company where he gained experience of working in an industrial laboratory. Tristan moved to Ireland in 2014 after choosing to study for a PhD at University College Dublin. The PhD research used molecular biology techniques to study infectious disease, specifically host-virus interactions. Tristan recently graduated from his PhD and joined the virology team at airmid healthgroup in the spring of 2019.  

 

Kevin Ellison

 

Kevin is in his third year at DCU where he has been studying Genetics and Cell biology. He is working in the Environmental Chambers under the supervision of Jake Behan.

 

Ireland - A highly attractive location for Research & Development

samuel beckett bridgeIreland's tax system and unique attributes as an investment location encourages both the creation and management of intellectual property (IP). IP has emerged as a central asset of the world's leading companies. Today, IP is sourced globally through diverse channels such as open innovation, university collaboration, joint venture or direct acquisition.

Ireland provides one of the leading jurisdictions in the world to create IP through research and development, since companies based in Ireland have the ability to reduce their effective corporation tax to as low as 2.5% on income arising from the management, development and exploitation of their IP. This can be achieved by taking advantage of Ireland's low corporation tax of 12.5%, generous R&D tax credits and competitive onshore IP regime. The new regime allowed for capital allowances to be claimed on IP acquired by an Irish company for the purposes of its trade and was introduced in the Finance Act 2009 in line with the commitment included in the Irish Government's Economic Recovery Plan, "Building Ireland's Smart Economy".

In addition to favourable tax conditions, Ireland also offers the following attributes;

  • World class research institutes and university programmes
  • No 1 world ranking for availability of skilled labour, flexibility and adaptability of workforce and attitudes towards globalisation, (source IMD World Competitiveness Yearbook 2012)
  • A transparent tax regime and commitment to its 12.5% corporation tax
  • Special Assignment Relief Programme to attract key talent to Ireland
  • Cultural affinity to the US
  • Barrier free access to over 500 million consumers in Europe

A wide range of US and other foreign companies have operations in Ireland, including Google, Microsoft, Facebook, Twitter, Accenture, Citi, Intel, HP & IBM. In addition 9 out of the top 10 global pharmaceutical companies, and 11 out of the top 13 global medical technology companies have manufacturing operations in Ireland. The opportunity to collaborate with Irish research facilities, coupled with generous government incentives for research and development has resulted in many companies now choosing Ireland as the location to house their global research and development centres.

airmid healthgroup can assist companies interested in setting up an Irish subsidiary company by connecting them with leading lawyers, tax advisors and IP experts who can investigate the costs and benefits of such an operation.

Further reading:

Screen Shot 2014-06-30 at 3.17.11 PM  Invest in Ireland

Screen Shot 2014-06-30 at 3.27.29 PM  Research and Development Tax Credit (RDTC)

Screen Shot 2014-06-30 at 3.29.13 PM Intangible Assets Scheme under Section 291A Taxes Consolidation Act 1997

irchss logo Irish Research Council

Print